ChemicalBook > CAS DataBase List > MI-3 (Menin-MLL Inhibitor)

MI-3 (Menin-MLL Inhibitor)

Product Name
MI-3 (Menin-MLL Inhibitor)
CAS No.
1271738-59-0
Chemical Name
MI-3 (Menin-MLL Inhibitor)
Synonyms
MI-3;CS-1809;5-dihydro-5;Menin-MLL inhibitor 3;MI-3 (Menin-MLL Inhibitor);MI-3 (Menin-MLL Inhibitor) USP/EP/BP;5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl);MI3,MI-3,Apoptosis,inhibit,Epigenetic Reader Domain,Inhibitor;4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)thieno[2,3-d]pyrimidine;Thieno[2,3-d]pyriMidine, 4-[4-(4,5-dihydro-5,5-diMethyl-2-thiazolyl)-1-piperazinyl]-6-(1-Methylethyl)-
CBNumber
CB42624233
Molecular Formula
C18H25N5S2
Formula Weight
375.55
MOL File
1271738-59-0.mol
More
Less

MI-3 (Menin-MLL Inhibitor) Property

Boiling point:
527.9±60.0 °C(Predicted)
Density 
1.36±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : 8.33 mg/mL (22.18 mM; Need ultrasonic)
form 
Powder
pka
9.59±0.40(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
27214
Product name
MI-3
Packaging
500μg
Price
$37
Updated
2024/03/01
Cayman Chemical
Product number
27214
Product name
MI-3
Packaging
1mg
Price
$65
Updated
2024/03/01
Cayman Chemical
Product number
27214
Product name
MI-3
Packaging
5mg
Price
$231
Updated
2024/03/01
TRC
Product number
M341040
Product name
MI-3(Menin-MLLInhibitor)
Packaging
5mg
Price
$185
Updated
2021/12/16
ChemScene
Product number
CS-0772
Product name
MI-3
Purity
99.73%
Packaging
10mg
Price
$252
Updated
2021/12/16
More
Less

MI-3 (Menin-MLL Inhibitor) Chemical Properties,Usage,Production

Description

MI-3 is an inhibitor of the interaction between menin and mixed lineage leukemia (MLL) fusion proteins (IC50 = 648 nM). MI-3 binds to menin (Kd = 201 nM) and inhibits the menin interaction with the MLL fusion protein MLL-AF9 in HEK293 cells without affecting protein levels of menin or MLL-AF9. It inhibits growth of mouse bone marrow cells (BMCs) expressing the Hoxa9 transformation-dependent MLL fusion proteins MLL-AF9 or MLL-ENL (IC50 = 5 μM for both), as well as reduces colony formation and induces differentiation of MLL-AF9-transformed BMCs. MI-3 inhibits growth of human leukemia cell lines containing MLL translocations and decreases the expression of the transcription factors HOXA9, HOXA10, and MEIS1 in THP-1 cells.

Uses

MI-3 (Menin-MLL Inhibitor) reverses oncogenic activity of MLL fusion proteins in leukemia.

MI-3 (Menin-MLL Inhibitor) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MI-3 (Menin-MLL Inhibitor) Suppliers

China 66 United Kingdom 1 United States 12 Global 79
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
18521735133 18521732826;
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
25015
Advantage
65
Hubei Jusheng Technology Co.,Ltd
Tel
027-59599241 18871490274
Fax
027-59599241
Email
1400878000@qq.com
Country
China
ProdList
9972
Advantage
58
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696，15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4153
Advantage
55
D&C Chemicals
Tel
+86-21-58447131
Fax
+86-21-61642470
Email
1724405207@qq.com
Country
China
ProdList
472
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9254
Advantage
55
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9926
Advantage
65
Pharmacodia (Beijing) Co.,Ltd
Tel
+86-400-851-9921
Fax
+86-10-82826195
Email
sales@pharmacodia.com
Country
China
ProdList
2317
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9709
Advantage
58

1271738-59-0, MI-3 (Menin-MLL Inhibitor)Related Search:

MI-136 SAR405838 (MI-773) MI-2 (Menin-MLL Inhibitor) Tazemetostat (EPZ-6438) ACY-1215 Panobinostat (2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol I-BET-762 OG-L002

  • MI-3
  • 5-dihydro-5
  • 5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)
  • MI3;MI 3;MENIN-MLL INHIBITOR 3;THIENO[2;3-D]PYRIMIDINE; 4-[4-(4;5-DIHYDRO-5;5-DIMETHYL-2-THIAZOLYL)-1-PIPERAZINYL]-6-(1-METHYLETHYL)
  • Menin-MLL inhibitor 3
  • Thieno[2,3-d]pyriMidine, 4-[4-(4,5-dihydro-5,5-diMethyl-2-thiazolyl)-1-piperazinyl]-6-(1-Methylethyl)-
  • 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)thieno[2,3-d]pyrimidine
  • MI-3 (Menin-MLL Inhibitor)
  • 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)thieno[2,3-d]pyrimidine MI-3
  • CS-1809
  • MI-3 (Menin-MLL Inhibitor) USP/EP/BP
  • MI3,MI-3,Apoptosis,inhibit,Epigenetic Reader Domain,Inhibitor
  • 1271738-59-0
  • Inhibitors